ePrints

Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.

Lookup NU author(s): Professor Luke ValeORCiD

Downloads

• Published version [.pdf]
• Published version [.pdf]

Licence

This is the final published version of an article that has been published in its final definitive form by National Coordinating Centre for Health Technology Assessment, 2011.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Hislop J, Quayyum Z, Elders A, Fraser C, Jenkinson D, Mowatt G, Sharma P, Vale L, Petty R

Publication type: Article

Publication status: Published

Journal: Health Technology Assessment

Year: 2011

Volume: 15

Issue: 25

Pages: 178

Print publication date: 01/06/2011

Date deposited: 16/05/2012

ISSN (print): 1366-5278

ISSN (electronic): 2046-4924

Publisher: National Coordinating Centre for Health Technology Assessment

URL: http://www.hta.ac.uk/2154

DOI: 10.3310/hta15250

Altmetrics

Share